According to Renub Research analysis China Biopsy Market will be USD 8.1 Billion by 2026. Forecast by Cancer Segment, Volume of Biopsy and Patient Diagnosed Numbers, Company Analysis. Follow the Link for More Information: https://www.renub.com/china-biopsy-market-p.php
iGATE Research has released a report on "Global - Biopsy Device Market (By Country Wise and Product Segment) and Biopsy Procedure Volume Analysis To 2020" Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20Biopsy%20Device%20Market%20and%20Forecast%20To%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com
The market for biopsy guidance systems held the largest share in 2015 and is expected to continue to lead the market throughout the forecasting period. The biopsy guidance systems is followed by the needle based biopsy guns segment. Vacuum-assisted biopsy devices represent the fastest growing segment, and increased Medicare reimbursement given for such procedures is expected to help fuel demand. The market for biopsy needles is expected to remain relatively constant throughout the forecasting period. Forceps and Other devices are expected to account for lesser shares as compared to the other segments, due to their specific applications and also risks associated with their use. Complete report available at: http://www.marketreportsonline.com/563956.html.
Polyp Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Polyp Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
In IVD market oncology is one of the most sought-after segments by the manufacturers. Non-invasive cancer testing is expected to be a hot market in 2019. Qiagen, one of the global MNC, has been pioneering the use of liquid biopsy-based companion diagnostics as a less-invasive option to complement surgical biopsies for genomic profiling of cancers.
This report studies the Prostate Biopsy Devices market status and outlook of global and major regions, from angles of players, regions, product types and end industries. Avail Sample Brochure of report http://bit.ly/2oTngVO Read analysis @ http://bit.ly/2pDZgVE
The blood cancer detection market is expected to continue to grow in the coming years, driven by the factors mentioned above. The development of new and improved diagnostic technologies, such as liquid biopsy, is expected to further drive the growth of the market. Liquid biopsy is a minimally invasive technique that can be used to detect blood cancer by analyzing cell-free DNA circulating in the blood.
The global Mammography market, valued at US$ 2.3 Billion in 2023, is expected to exhibit a robust growth trajectory, expanding at a CAGR of 11.6% from 2024 to 2033, reaching US$ 6.9 Billion by the end of the forecast period. Digital Systems are anticipated to emerge as the highest revenue-generating segment, also witnessing a CAGR of 11.6%. Driving this growth are factors such as an aging population, a rise in hormonal imbalances and breast cancer cases, advancements in imaging technologies, and increased funding for breast cancer screening programs. However, barriers such as lack of awareness, patient discomfort, and potential adverse effects may hinder market growth.
According to the latest research report by IMARC Group, The global idiopathic pulmonary fibrosis treatment market size reached US$ 3,848.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,980.4 Million by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. More Info:- https://www.imarcgroup.com/idiopathic-pulmonary-fibrosis-treatment-market
Liquid Biopsy Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product & Services (Equipment, Reagents & Kits, and Services), Sample (Blood Based, Urine Based, and Other Samples), Circulating Biomarker [Circulating Tumor Cells (CTC), Exosomes, and Free Nucleic Acid], Application [Noninvasive Prenatal Testing (NIPT), Oncology, Transplant Diagnostics, and Other Applications], and End User (Academic & Research Institutes, Hospitals, Reference Laboratories, and Other End Users)
The growth of the studied market is driven due to the rising incidence of oncology diseases, the need for efficient prognosis and early diagnosis of various forms of cancer, and rising initiatives by key players in the development of innovative solutions to meet the increasing demand for efficient diagnostics. Several tests, including physical examination, laboratory tests, imaging tests, and biopsies have traditionally been performed in cancer diagnosis. Each step of the usual diagnostic procedure with the prognosis and therapeutic decision made by oncologists comes with a well-defined diagnosis to avoid potential complications. This highlights the crucial importance of diagnosis throughout the entire oncology lifecycle, surpassing the therapeutic regime's significance.
Liquid biopsy reduces the apprehension of patients regarding pain and provides a safe and effective method of diagnosis. As a result, there has been increasing demand for a non-invasive alternative, such as liquid biopsy, over tissue biopsy that involves the painful extraction of diseased tissue, which is fueling the market growth. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/liquid-biopsy-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
MarkNtel Advisors, in its latest report, forecasts a Compound Annual Growth Rate (CAGR) of approximately 8.6% for the Global Breast Cancer Treatment Market throughout the forecast period (2022-27).
According to the latest research report by IMARC Group, The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028. More Info:- https://www.imarcgroup.com/liquid-biopsy-market
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
MarkNtel Advisors, in its latest report, forecasts a Compound Annual Growth Rate (CAGR) of approximately 8.6% for the Global Breast Cancer Treatment Market throughout the forecast period (2022-27).
The Asia Pacific cancer screening market is estimated to garner a revenue of USD 142542.43 Million by the end of 2030, by growing at a CAGR of 13.37% over the forecast period, i.e., 2021 – 2030.
The global interventional pulmonology market size was USD 1.36 Billion in 2022 and is expected to reach USD 2.31 Billion by 2032, and register a rapid revenue CAGR of 5.3% during the forecast period. Rising prevalence of respiratory illnesses and demand for minimally invasive procedures and developments in interventional pulmonology technology are major factors driving market revenue growth.
The Global Dermatology Devices Market is likely to progress $32330.43 million by 2030, with a CAGR of 13.06% during the forecast period 2023-2030. Read More
The biopsy devices market is anticipated to reach US$ 3,584.20 million by 2027 from US$ 2,230.86 million in 2019. The market is projected to grow at a CAGR of 6.2% from 2020 to 2027.
The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028.
iGATE Research has released a research report on “Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=144 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
iGATE Research has released a research report on “Biopsy Devices Market (By Product Segment, Application, End Users, and Country) and Biopsy Procedure Volume Analysis, Mergers and Acquisitions, Recent Developments, Trends, 15 Company Profiles & Biopsy Product Analysis – Global Forecast to 2025” Click here to view the complete report: https://www.igateresearch.com/biopsy-devices-market-by-product-segment-application-end-users-and-country-and-biopsy-procedure-volume-analysis-mergers-and-acquisitions-recent-developments-trends-15-company-profiles-biopsy-product-analysis-global-forecast-to-2025.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027.
The needle biopsy market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.2% in the forecast period of 2021 to 2028 and is expected to reach USD 154.18 million by 2028.
Surge in number of cancer patients and rise in preference for minimally invasive procedures are some key factors driving liquid biopsy market revenue growth
The global liver disease management market size reached USD 22.05 Billion in 2021 and is expected to register a revenue CAGR of 5.6% during the forecast period, according to latest analysis by Emergen Research. Rising demand for liver disease management in various imaging applications for industrial and manufacturing purposes in addition to increasing alcohol consumption are some of the factors driving market revenue growth. Companies are launching pipeline drugs, and ongoing clinical trials by several industries are also driving the market revenue growth of liver disease management.
The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027.
The Asia Pacific cancer screening market is estimated to garner a revenue of USD 142542.43 Million by the end of 2030, by growing at a CAGR of 13.37% over the forecast period, i.e., 2021 – 2030.
The global aspiration & biopsy needles market size was USD 875.3 Million in 2021 and is expected to register a revenue CAGR of 6.8% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of cancer cases owing to various lifestyle changes, rapid urbanization and rising pollution levels, and changing consumption habits and increasing cancer awareness programs and screening and tests by governments and various global health organizations are some of the key factors driving global aspiration and biopsy needles market revenue growth. According to World Cancer Research Fund International, around 18,094,716 million cases of cancer were diagnosed in 2020.
Global High intensity focused ultrasound (HIFU) Market will be US$ 548.6 Million by 2026. Forecast by Application(Prostate Cancer, Neurological Disorder, Cosmetic Medicine, Uterine Fibroids), Company Analysis
This report studies Stereotacticguided Biopsy Instrument in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering C. R. Bard, Inc. U.S. Becton, Dickinson and Company U.S.
Get a Sample Brochure @ https://tinyurl.com/y939vl8m Fibereoptic Bronchoscopy Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
Noninvasive cancer diagnostics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 5.30% in the above mentioned forecast period. Broadening information amidst the doctors and inmates concerning the advantages and availability of equipment will assist in encouraging the growth of the market.
Looking forward, the idiopathic pulmonary fibrosis treatment market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/idiopathic-pulmonary-fibrosis-treatment-market
The increasing prevalence of the disease represents one of the significant factors strengthening the biopsy devices market growth. Apart from this, the increasing awareness among individuals about the availability of diagnostic and screening procedures for chronic diseases is positively influencing the demand for integrated technologies, such as stereotactic-guided biopsies. For more information, request for a free sample report here: https://www.imarcgroup.com/biopsy-devices-market/requestsample
Giant cell arteritis is a rare disease of inflammation of blood vessels thereby restricting the flow of blood and damaging vital organs. Giant cell arteritis is the inflammation of blood vessels, veins and arteries in the head, neck and arms.
The growing prevalence of infectious diseases and high prevalence is a major factor driving the growth of the global infectious disease market. In addition, technological advances in diagnostic instruments, the government's initiative to develop appropriate healthcare infrastructure in emerging economies, and a greater understanding of diagnosis in developed economies will enhance the development of the global infectious disease diagnostics..
Looking forward, the biopsy devices market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/biopsy-devices-market
A new study on the global Liquid Biopsy market has been published by AllTheResearch (ATR). It offers detailed information on key market dynamics, including drivers, trends, and challenges for the global Liquid Biopsy market as well as its structure. The study offers valuable information on the global Liquid Biopsy market to illustrate how the market is expected to expand during the forecast period i.e. 2020–2023.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Vacuum-assisted Biopsy Devices in these regions, from 2012 to 2023 (forecast), covering North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
"United States General Surgery Market Outlook to 2020", provides key market data on the United States General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories - Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices. See Full Report @ bit.ly/1wL9VIN
“Brazil General Surgery Market Outlook to 2020", provides key market data on the Brazil General Surgery devices market. The report provides value, in millions of US dollars, and volume (in units) within market categories - Bronchoscopes, Laryngoscopes, Ureteroscopes, Cystoscopes, Colonoscopes, Sigmoidoscopes, Esophagoscopes & Gastroscopes, Duodenoscopes, Laparoscopes, Hysteroscopes, Sinuscopes, Resectoscopes, Endoscopy Visualization Systems, Endoscopy Visualization System Components, Endoscopic Reprocessors, Endoscopy Fluid Management Systems, Capsule Endoscopy Systems, Surgical Generators, Bariatric Surgery Devices, Aesthetic Lasers and Energy Devices, Biopsy Devices, Hernia Repair, Non-Vascular Stents and Gynecological Devices. See Full Report : http://bit.ly/1D9eKix
We distribute customized reports that focus on meeting the client’s specific requirement. Our database consists of a large collection of high-quality reports, obtained using a customer-centric approach, thus providing valuable research insights.
Kaposi sarcoma market has increased at a CAGR of 2.25% over the forecast period that will exhibit valuation of USD 0.15 billion by 2024 rising from USD 0.11 billion in 2016
Get a Sample Brochure @ https://tinyurl.com/y9pstcpv 2016 Global Endoscopy Tower Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Endoscopy Tower industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).